Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:39:168-171.
doi: 10.1016/j.ijscr.2017.07.062. Epub 2017 Aug 18.

Biopsy-proven progressive fatty liver disease nine months post mini-gastric bypass surgery: A case study

Mohammad Ali Kalantar Motamedi  1 , Nasser Rakhshani  2 , Alireza Khalaj  3 , Maryam Barzin  4
Affiliations

Biopsy-proven progressive fatty liver disease nine months post mini-gastric bypass surgery: A case study

Mohammad Ali Kalantar Motamedi et al. Int J Surg Case Rep. 2017.

Abstract

Introduction: Mini-gastric bypass (MGB) is a popular bariatric procedure. Its effect on non-alcoholic fatty liver disease (NAFLD), however, has not yet been comprehensively studied.

Presentation of case: A 57 year-old non-alcoholic female with a body mass index of 42.8kg/m2 underwent MGB without any incident. A concurrent liver biopsy showed an NAFLD activity score (NAS) of 2/8 without fibrosis. She presented at postoperative month eight with edema, vague abdominal pain, nausea, and vomiting and was hospitalized. Her BMI had dropped to 25.7kg/m2. Her blood workup revealed mild anemia, mildly elevated liver enzymes, and hypoalbuminemia (2.5g/dL). Liver ultrasound revealed grade-2 fatty liver. She received parenteral nutrition and intensive nutrient supplementation. Nevertheless, with regard to unsuccessful supportive measures and rising liver enzymes, revisional surgery -gastrogastrostomy- was performed. Her liver biopsy demonstrated a NAS of 7/8 at the time of revisional surgery. Her postoperative course was uneventful and she was discharged after one week.

Discussion: Bariatric surgery has shown favorable results regarding improvement of NAFLD in morbid obesity. This beneficial effect has been linked to the amount of weight loss. However, case reports have shown deteriorating liver function and NAFLD even after significant weight loss. They all have in common significant weight loss in a relatively short period of time. There may also be a connection between specific bariatric surgery procedures and this phenomenon.

Conclusion: Future studies comparing the effect of various bariatric procedures, including MGB, are necessary to help clinicians decide the optimal procedure for patients with this liver condition.

Keywords: Bariatric surgery; Case report; Hepatic insufficiency; Mini-gastric bypass; Non-alcoholic fatty liver disease.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(A) Photomicrograph at primary bariatric surgery, showing ballooning (arrow) and steatosis (arrowhead). (B) Photomicrograph at revisional surgery, showing more prominent ballooning (arrows), steatosis (arrowhead), and neutrophilic satellitosis (circles).
See this image and copyright information in PMC

References

    1. Lee W.J., Ser K.H., Lee Y.C., Tsou J.J., Chen S.C., Chen J.C. Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes. Surg. 2012;22(12):1827–1834. - PubMed
    1. Agha R.A., Fowler A.J., Saeta A., Barai I., Rajmohan S., Orgill D.P. The SCARE statement: consensus-based surgical case report guidelines. Int. J. Surg. 2016;34:180–186. - PubMed
    1. Barzin M., Hosseinpanah F., Motamedi M.A., Shapoori P., Arian P., Daneshpour M.A. Bariatric surgery for morbid obesity: Tehran Obesity Treatment Study (TOTS) rationale and study design. JMIR Res. Protoc. 2016;5(1):e8. - PMC - PubMed
    1. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–1321. - PubMed
    1. 2012. Guidelines WGOG. Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: World Gastroenterology Organisation.http://www.worldgastroenterology.org/NAFLD-NASH.html Available from: